ArticleIndian journal of ophthalmology2021
Validating tablet perimetry against standard Humphrey Visual Field Analyzer for glaucoma screening in Indian population.
Article in Indian journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.
- Diagnostic accuracy and reliability of portable visual field-testing devices for detecting manifest glaucomatous visual-field loss: a systematic review and meta-analysis.BMC ophthalmology · 2026Pooled it
- Virtual reality headsets for perimetry testing: a systematic review.Eye (London, England) · 2024Pooled it
- A comparative analysis of an AI-assisted virtual reality platform with technician-based examination for visual field, visual acuity, and color vision in neuro-ophthalmology.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Evaluating the effect of systemic hypertension on retinal, optic nerve head microvasculature and field of vision using optical coherence tomography angiography and visual field analyzer.BMC ophthalmology · 2025Observational
- Comparative Analysis of Melbourne Rapid Fields Web-Browser Perimeter and Humphrey Field Analyzer in Chinese Glaucoma Patients.Translational vision science & technology · 2025Article
- Development and Validation of an Internet-Based Remote Perimeter (Perimouse).Translational vision science & technology · 2024Article
- Diagnostic accuracy of an iPad application for detection of visual field defects.Eye (London, England) · 2023Article
- Circular Contrast Perimetry via Web Application: A Patient Appraisal and Comparison to Standard Automated Perimetry.Ophthalmology science · 2022Article
- Spotlight on iPad Visual Field Tests Efficacy.Clinical ophthalmology (Auckland, N.Z.) · 2022Review
- [Is home perimetry possible?]Archivos de la Sociedad Espanola de Oftalmologia · 2021Article
- Response to comments on: Validating tablet perimetry against standard Humphrey Visual Field Analyzer for glaucoma screening in Indian population.Indian journal of ophthalmology · 2021Article
- Comments on: Validating tablet perimetry against standard Humphrey Visual Field Analyzer for glaucoma screening in Indian population.Indian journal of ophthalmology · 2021Article
- Commentary: Evolving role of portable visual field testing in communities.Indian journal of ophthalmology · 2021Article
- Sensitivity and Specificity of New Visual Field Screening Software for Diagnosing Hemianopia.Eye and brain · 2021Article
- Commentary: Innovations in technology hold promise for glaucoma detection in underserved populations.Indian journal of ophthalmology · 2021Article
- Prospective Comparison of VisuALL Virtual Reality Perimetry and Humphrey Automated Perimetry in Glaucoma.Journal of current glaucoma practiceArticle
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
4 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The aim of this study was to determine the correlation between the perimetric outcomes using a free application program of the iPad, 'Visual Fields Easy' (VFE), and Humphrey Visual Field Analyzer (HVFA), in normal as well as eyes with glaucomatous damage of varying severity. Methods: In this prospective, cross-sectional, observational pilot investigation, visual field testing was carried out in 210 eyes of 210 patients (60 Normal, 150 Glaucoma), using suprathreshold VFE application (Version 8) on the iPad and Standard White-on-White using HVFA. Severity of glaucoma was categorized using Hodapp-Anderson-Parrish criteria for visual field defects. The results of the VFE program were compared to the 24-2 SITA FAST HVFA. Results: Data of 210 patients, 100 (47.6%) females, and 110 (52.4%) males, age ranging from 42 to 78 years, Mean 56.64 ± 10.67 years, was analyzed. The Spearman correlation coefficient showed a significant inverse relationship between missed points on the VFE app with MD (S = -0.783) and a parabolic relationship with PSD (S = 0.646) values obtained with the HVFA. As regards missed points, for mild glaucoma, missed points were 37.5, sensitivity was 77.8% and specificity was 52.6%; for moderate glaucoma, missed points were 33.5, sensitivity was 90% and specificity was 48% while for severe glaucoma, missed points were 23, sensitivity was 97% and specificity was 70%. AROC for eyes with mild glaucoma versus normal was 0.419 (95% CI: 0.343-0.495), moderate glaucoma versus normal was 0.705 (95% CI: 0.630-0.780) and severe glaucoma versus normal was 0.857 (95% CI: 0.806-0.908). Conclusion: Suprathreshold perimetry using VFE is not suitable as a rapid screening tool for mass screening of glaucoma. VFE cannot be used as a substitute for HVFA in clinic because of its inability to detect early or moderate glaucoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.